Lei Zhang | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Prof. Lei Zhang | Clinical Neuroscience | Research Excellence Award

Prof. Lei Zhang | The First Affiliated Hospital of Wenzhou Medical University | China

Lei Zhang is a male Chinese orthopaedic surgeon and scientist, currently serving as Professor, Chief Director, and Master Supervisor in the Department of Orthopaedics at The First Affiliated Hospital of Wenzhou Medical University. He holds both M.D. and Ph.D. degrees from the School of Medicine, Zhejiang University, and specializes clinically in arthroplasty and sports medicine, with a scientific focus on tissue engineering for bone and cartilage repair. His international training includes fellowships at Graz University, Singapore General Hospital, WaldKrankenhaus Hospital in Bonn, Peking University Third Hospital, JST Hospital, and Ewha Womans University Seoul Hospital, reflecting broad exposure to advanced orthopaedic techniques and translational research. Professor Zhang is actively engaged in professional service, holding leadership and membership roles in multiple branches of the Zhejiang Medical Association and related orthopedic, sports medicine, and tissue repair societies. He also contributes to academic publishing as Chief Editor of special issues in Frontiers in Bioengineering and Biotechnology and as Associate Editor for the Injury Prevention and Rehabilitation specialty in Frontiers in Sports and Active Living. His scholarly output includes 89 published documents, with 4,362 total citations from 4,083 citing documents and an h-index of 28, demonstrating sustained impact in orthopaedics, sports medicine, and regenerative tissue engineering.

Citation Metrics (Scopus)

8000
6000
4000
2000
0

Citations
4362

Documents
89

h-index
28

Citations

Documents

h-index


View Scopus Profile
 View Google Scholar Profile
 View Orcid Profile

Featured Publications

Seyed MohamadMehdi Moshtaghion | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Seyed MohamadMehdi Moshtaghion | Clinical Neuroscience | Research Excellence Award

Dr. Seyed MohamadMehdi Moshtaghion | Cabimer | Spain

Seyed MohamadMehdi Moshtaghion, MD, MSc, is a physician-scientist and Senior Research Technologist specializing in advanced therapies and diagnostic biomarkers for retinal degenerative diseases, with a primary focus on retinitis pigmentosa and age-related macular degeneration. His research integrates molecular biology, stem cell–based strategies, gene therapy, and artificial intelligence–driven retinal imaging to advance early diagnosis and personalized treatment approaches for vision-threatening disorders. He holds a medical degree from Shahid Beheshti University and advanced postgraduate training in biomedical investigation and molecular biology and biomedicine from the University of Seville, along with certification in animal experimentation. Dr. Moshtaghion has conducted research at leading international institutions, including Massachusetts Eye and Ear at Harvard Medical School, Karolinska Institutet, and CABIMER, contributing to translational projects that bridge laboratory discoveries with clinical ophthalmology. He has authored over 20 peer-reviewed scientific publications, with a total of 183 citations, an h-index of 8, and an i10-index of 8, reflecting consistent scholarly impact in the fields of retinal biology and regenerative medicine. His work has been presented at major international conferences such as ARVO and EURETINA, highlighting innovative therapeutic strategies and biomarker discovery in retinal disease research.

Citation Metrics (Google Scholar)

400
300
200
100
0

Citations
183

Documents
20

h-index
8

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Interpretable deep learning for diagnosis of fungal and acanthamoeba keratitis using in vivo confocal microscopy images
– M Essalat, M Abolhosseini, TH Le, SM Moshtaghion, MR Kanavi, Scientific Reports, 13(1): 8953, 2023

Penetrating keratoplasty versus deep anterior lamellar keratoplasty in children and adolescents with keratoconus
– S Feizi, MA Javadi, F Karimian, M Abolhosseini, SM Moshtaghion, American Journal of Ophthalmology, 226: 13–21, 2021

Impression cytology for detection of clinically suspected ocular surface disorders: a cross-sectional study
– SM Moshtaghion, M Abolhosseini, MR Kanavi, SB Hosseini, European Journal of Ophthalmology, 31(3): 943–950, 2021

Outcomes of big-bubble deep anterior lamellar keratoplasty for pediatric keratoconus
– S Feizi, MA Javadi, M Najafi, M Abolhosseini, SM Moshtaghion, International Ophthalmology, 40(5): 1253–1259, 2020

Anna Fleischer | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Anna Fleischer | Clinical Neuroscience | Research Excellence Award

Dr. Anna Fleischer | University Hospital Würzburg | Germany

Anna Fleischer is a Clinician Scientist and Assistant Doctor at the University Hospital Würzburg, Department of Internal Medicine II, specializing in psychosomatic medicine and innovative myeloma therapy. She holds a Dr. med., a Master of Science in Translational Medicine, and a Master of Health Business Administration, reflecting her strong integration of clinical care, translational research, and healthcare leadership. She is the inventor and project leader of the ENDOLEASE platform, a biodegradable intra-arterial drug delivery system designed to enhance therapeutic precision and efficacy, and also leads GUSTABOR, a digital companion for taste-related supportive care in oncology, alongside multiple completed and ongoing projects in multiple myeloma and CAR-T cell therapy. Her research interests focus on patient involvement, side-effects management, digitalization, and improving therapeutic outcomes across oncology, cardiology, and neurology. Dr. Fleischer has received numerous honors, including the Medical Valley Award and the Bätz-Preis, and is an elected member of Sigma Xi, The Scientific Research Honor Society, recognized for outstanding research achievements. She actively collaborates with industry and academic partners such as BioM, IGZ Würzburg, and MIT/Harvard, and is an inventor on an internationally published patent for endovascular drug delivery owned by the University of Würzburg. Her scholarly impact is reflected in an h-index of 6, with 13 documents receiving 79 citations, underscoring her growing influence in translational and clinical research.

Citation Metrics (Scopus)

90
60
30
0

Citations
79

Documents
13

h-index
6

Citations

Documents

h-index

View Scopus Profile

Featured Publication

Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Fiona Stanley | Australia

Dr. Hendry Ramly is a clinician–researcher with advanced training in general medicine, cardiology, and intensive care medicine, and a focused academic interest in non-traumatic out-of-hospital cardiac arrest and post-resuscitation care. His research is directly informed by frontline clinical practice across acute medicine, ICU, and cardiology, where he manages critically ill patients following cardiac arrest. Dr. Ramly’s primary research examines cardiovascular management strategies after return of spontaneous circulation, with particular emphasis on haemodynamic stabilisation, coronary pathology, and the timing and utility of urgent coronary angiography. Neurological outcomes are included as standard clinical endpoints, while the central focus remains on cardiovascular determinants of survival and in-hospital mortality. He is lead author of a retrospective observational cohort study published in Heart, Lung and Circulation (2025), evaluating outcomes of non-traumatic out-of-hospital cardiac arrest at a tertiary centre. His additional audit work includes thoracic surgical outcomes, geriatric referral pathways, and procedural adequacy in respiratory medicine. Through clinically driven research and multidisciplinary collaboration, Dr. Ramly aims to refine evidence-based pathways that improve survival, decision-making, and quality of care for patients following cardiac arrest.


View ORCID Profile

Featured Publication

Hui Zhang | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Hui Zhang | Clinical Neuroscience | Best Researcher Award

Prof. Hui Zhang | Northwestern University | United States

Hui Zhang is a Professor in the Division of Biostatistics, Department of Preventive Medicine at Northwestern University Feinberg School of Medicine, where he also holds appointments at the Robert H. Lurie Comprehensive Cancer Center, the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease, and the Center for Epidemiology and Population Health. he serves as Director of the Northwestern Brain Tumor SPORE Biostatistics and Bioinformatics Core and leads the Biostatistics and Data Management Core at the Mesulam Center. With a Ph.D. in Statistics from the University of Rochester, her academic foundation spans pharmacology, neurophysiology, and biology, reflecting her interdisciplinary expertise in biostatistics and biomedical research. His previous experience includes research roles at St. Jude Children’s Research Hospital, where she contributed significantly to clinical and statistical protocol development. Professor Zhang’s work focuses on statistical methodologies for cancer and neurological disease research, data integration, and bioinformatics applications. he is an active member of several professional societies, including the American Statistical Association and the International Chinese Statistical Association. A highly cited researcher, she has accumulated over 11,422 citations, an h-index of 43, and an i10-index of 100, demonstrating her substantial impact and leadership in the fields of biostatistics and medical data science.

Profile: Google Scholar

Featured Publications

Moss, A. J., Hall, W. J., Cannom, D. S., Klein, H., Brown, M. W., Daubert, J. P., et al. (2009). Cardiac-resynchronization therapy for the prevention of heart-failure events. New England Journal of Medicine, 361(14), 1329–1338.

Gunzler, D., Chen, T., Wu, P., & Zhang, H. (2013). Introduction to mediation analysis with structural equation modeling. Shanghai Archives of Psychiatry, 25(6), 390–394.

Wan, T., Jun, H. U., Pan, W. U., & Hua, H. E. (2015). Kappa coefficient: A popular measure of rater agreement. Shanghai Archives of Psychiatry, 27(1), 62–67.

Pu, J., Wang, S., Yin, Y., Zhang, G., Carter, R. A., Wang, J., Xu, G., Sun, H., Wang, M., et al. (2015). Evolution of the H9N2 influenza genotype that facilitated the genesis of the novel H7N9 virus. Proceedings of the National Academy of Sciences, 112(2), 548–553.

Guy, C. S., Vignali, K. M., Temirov, J., Bettini, M. L., Overacre, A. E., Smeltzer, M., et al. (2013). Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nature Immunology, 14(3), 262–270.

Shen, S., Chen, X., Cai, J., Yu, J., Gao, J., Hu, S., Zhai, X., Liang, C., Ju, X., Jiang, H., et al. (2020). Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome–positive acute lymphoblastic leukemia: A randomized clinical trial. JAMA Oncology, 6(3), 358–366.

Sonabend, A. M., Gould, A., Amidei, C., Ward, R., Schmidt, K. A., Zhang, D. Y., et al. (2023). Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: A phase 1 trial. The Lancet Oncology, 24(5), 509–522.

Kushal J | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mr. Kushal J | Clinical Neuroscience | Best Researcher Award

Mr. Kushal J |  Acharya and B M Reddy College of Pharmacy | India

Kushal J’s research focuses on pharmaceutical analysis, drug formulation, and healthcare innovation, reflecting a deep interest in bridging traditional and modern approaches to drug development. His work includes the formulation, development, and evaluation of an anti-acne serum using cow’s urine, a study that explores bioactive natural resources for dermatological applications. He has also contributed to analytical chemistry through his project on analytical method development and validation for identifying selected genotoxic impurities in bulk and pharmaceutical dosage forms by the RP-HPLC DAD method, presented at the JSS Pharmanecia International Research Conference. His academic training emphasizes analytical instrumentation, including HPLC, UV-Vis spectrophotometry, and dissolution testing, supported by a strong understanding of Good Laboratory Practices (GLP) and Good Manufacturing Practices (GMP). He has further strengthened his theoretical foundation through certifications in Food Chemistry and Biomedical Research. Kushal’s growing research portfolio highlights his dedication to advancing pharmaceutical quality control, regulatory compliance, and innovation in formulation science. His goal is to apply analytical and formulation expertise toward developing safer, more effective, and sustainable pharmaceutical products, contributing to the evolving fields of pharmaceutical technology, analytical method development, and health informatics.

Profile: Orcid

Featured Publication

Kushal, J., Loganathan, C. G., Rajesh, R., Dutta, S., Paik, A., Dasgupta, A., Reddy, G. N. N., & Suchindar, A. (2025). Recent advances in quinoline derivatives: Biological and medicinal insights. ChemistrySelect.

Calixto Machado | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Calixto Machado | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Calixto Machado | Institute of Neurology and Neurosurgery | Cuba

Calixto Machado is a Full Professor and Senior Researcher in Neurology and Clinical Neurophysiology at the Institute of Neurology and Neurosurgery in Havana, Cuba, and a Corresponding Fellow of the American Academy of Neurology. He completed his medical degree, followed by specialist training in neurology and clinical neurophysiology, and then earned his PhD. Over four decades he has led pioneering research on disorders of consciousness, brain death, stroke, autism, autonomic nervous system disorders and the neurological sequelae of SARS-CoV-2. He has published nearly 700 peer-reviewed journal articles, book chapters and authored seven books; his work is recognised internationally through numerous symposia and awards. His Google Scholar profile lists an h-index of 37, and over 24 000 citations across his published documents.

Profile: Google Scholar

Featured Publications:

Machado, C. (2025, September 9). Jahi McMath case: A comprehensive and updated narrative. World Journal of Critical Care Medicine, 14(3), 107513.

Machado, C. (2022). The Jahi McMath case: First detailed study of her brain. Neurology India, 70(5), 22–35.

Giacino, J. T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D. I., Kelly, J. P., & others. (2002). The minimally conscious state: Definition and diagnostic criteria. Neurology, 58(3), 349–353.

Sloan, M. A., Alexandrov, A. V., Tegeler, C. H., Spencer, M. P., Caplan, L. R., & others. (2004). Assessment: Transcranial Doppler ultrasonography report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 62(9), 1468–1481.

Machado, C. (2002). Brain death worldwide: Accepted fact but no global consensus in diagnostic criteria. Neurology.

Machado, C. (2007). Cerebral response to patient’s own name in the vegetative and minimally conscious states. Neurology, 69(7), 708.

Machado, C., Korein, J., Ferrer, Y., Portela, L., & others. (2007). The concept of brain death did not evolve to benefit organ transplants. Journal of Medical Ethics, 33, 197–200.

Machado, C. (2007). The concept of brain death did not evolve to benefit organ transplants. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2007). Brain death: A reappraisal. Springer Science & Business Media.

Machado, C. (2007). The first organ transplant from a brain-dead donor. In C. Machado (Ed.), Brain death: A reappraisal (pp. 1–20). Springer.

Machado, C. (2010). Diagnosis of brain death. Neurology International, 2(1), e2.

Graf, W. D., Miller, G., Epstein, L. G., & Rapin, I. (2017). The autism “epidemic”: Ethical, legal, and social issues in a developmental spectrum disorder. Neurology, 88(14), 1371–1380.

Machado, C., Korein, J., Aubert, E., Bosch, J., Alvarez, M. A., Rodríguez, R., & others. (2007). Recognizing a mother’s voice in the persistent vegetative state. Clinical EEG and Neuroscience, 38(3), 124–126.

Lewis, A., Bernat, J. L., Blosser, S., Bonnie, R. J., Epstein, L. G., Hutchins, J., & others. (2018). An interdisciplinary response to contemporary concerns about brain death determination. Neurology, 90(9), 423–426.*

Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award

Published on by Neuroscientists

Dr. Kathrin Eichinger | Clinical Neuroscience | Outstanding Contribution Award 

Dr. Kathrin Eichinger | Medizinische Universitat Wien | Austria

Dr. Med. Kathrin Eichinger is an Austrian physician specializing in Pediatrics and Pediatric Neurology, currently serving as a Consultant in Child and Adolescent Medicine with subspecialty training in Neuropediatrics at the Medical University of Vienna. Her clinical and academic focus lies in neuroimmunology, with ongoing doctoral research in neuroscience examining acute necrotizing encephalitis. Dr. Eichinger’s experience spans several leading medical institutions, including Sankt Anna Children’s Hospital and the Hospital of the Brothers of Mercy in Eisenstadt, complemented by an observership in Neurointensive Care and Neuroimmunology at the Children’s Hospital of Philadelphia. She has also contributed to clinical research through her involvement in the eSMART randomized controlled trial on electronic symptom management at the Medical University of Vienna. Her expertise is further supported by certification in pediatric EEG and active participation in numerous neuropediatric congresses and workshops across Europe. Multilingual in German, English, and Spanish, Dr. Eichinger combines her clinical acumen with strong research engagement, reflected in her growing academic footprint with an h-index of 3, five peer-reviewed documents, and approximately 45 citations. Her professional pursuits integrate advanced clinical training, translational neuroscience, and a dedication to improving pediatric neurocare.

Profile: Orcid

Featured Publications

  • Eichinger, K., Breu, M., Renken, M., Siegert, S., Hilz, E., Glatter, S., Csaicsich, D., Boehm, M., Lechner, C., Kornek, B., et al. (2025). Complications of therapeutic plasma exchange in pediatric neuroimmune disorders. Children, 12(11), 1457.

  • Grasl, S., Janik, S., Dressler, A., Diehm, R., Gröppel, G., Eichinger, K., Grasl, M. C., Gstoettner, W., Feucht, M., Vyskocil, E., et al. (2021). Management and outcome of vagus nerve stimulator implantation: Experience of an otolaryngeal/neuropediatric cooperation. European Archives of Oto-Rhino-Laryngology, 278(10), 3729–3738.

Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Dr. Seyyed Ali | Zendehbad University of Mazandaran | Iran

Dr. Seyyed Ali Zendehbad is a multidisciplinary researcher specializing in biomedical signal processing, cognitive computational neuroscience, and neurorehabilitation technologies. His research integrates deep learning, pattern recognition, and multimodal biological data modeling to enhance fatigue detection and neurorehabilitation systems. He has authored several peer-reviewed papers in reputable journals such as Scientific Reports, IEEE Access, Sensing and Bio-Sensing Research, and Healthcare Technology Letters, focusing on hybrid AI frameworks, EMG signal processing, and muscle synergy-based biofeedback mechanisms. Dr. Zendehbad’s work on developing intelligent rehabilitation systems, including his models like TraxVBF and FatigueNet, contributes to advancing telemonitoring and assistive technologies for neurological recovery. His scholarly output includes more than 25 documents, over 600 citations, and an h-index of 12, reflecting his growing impact in computational neuroscience and biomedical engineering. Recognized for innovation, he has achieved first-place awards in multiple national startup competitions and was honored with the Best Poster Award at the Congress of Neurology and Clinical Electrophysiology of Iran. As a postdoctoral researcher at the University of Mazandaran, his ongoing work emphasizes integrating trustworthy AI into telehealth systems, promoting equitable and efficient digital healthcare delivery through interdisciplinary research and technological innovation.

Profile: Orcid

Featured Publications

1. Mazrooei Rad, E., Mazinani, S. M., & Zendehbad, S. A. (2025). Diagnosis of Alzheimer’s disease using non-linear features of ERP signals through a hybrid attention-based CNN-LSTM model. Computer Methods and Programs in Biomedicine Update, 5, 100192.

2. Zendehbad, S. A., Sharifi Razavi, A., Tabrizi, N., & Sedaghat, Z. (2025). A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective. Epilepsy Research, 207, 107582.

3. Mazrooei Rad, E., Zendehbad, S. A., & Hosseinzadeh, V. (2025). Fetal QRS complex detection based on adaptive filters and peak detection. Research on Biomedical Engineering, 41(3), 424–438.

4. Zendehbad, S. A., Ghasemi, J., & Samsami Khodadad, F. (2025). FatigueNet: A hybrid graph neural network and transformer framework for real-time multimodal fatigue detection. Scientific Reports, 15(1), 640.

5. Safdel, A., Zendehbad, S. A., & Ghasemi, J. (2025). Advanced deep learning approaches for accurate and efficient suspicious behavior detection in surveillance videos. Computational Sciences and Engineering, 21(2), 1099.

Maria -Camelia Stancioaica | Clinical Neuroscience |

Published on by Neuroscientists

Ms. Maria -Camelia Stancioaica | Clinical Neuroscience | Best Researcher Award

Ms. Maria -Camelia Stancioaica | Fundeni Clinical Hospital | Romania

Dr. Maria Camelia Stăncioaica is a dedicated Romanian hematologist affiliated with the Fundeni Clinical Institute in Bucharest, where she serves as the Acute Leukemia Program Coordinator. She holds an M.D. in Clinical Hematology and is currently pursuing her Ph.D. at the Carol Davila University of Medicine. Her professional development includes international experience through observership at Johns Hopkins Hospital in the USA and an internship at Pitié–Salpêtrière Hospital in France. Dr. Stăncioaica has contributed to advancing hematologic research through publications addressing acute leukemia, fungal infections in immunocompromised patients, and targeted therapies in acute myeloid leukemia. Her notable works include studies on FLT3 inhibitors, differentiation syndrome in pregnancy, and invasive fusariosis outbreaks. Actively engaged in global scientific dialogue, she has been a speaker and session chair at prominent hematology conferences across Europe. She also participates in several clinical trials as both principal and subinvestigator, focusing on novel therapeutic strategies in leukemia management. Dr. Stăncioaica’s research achievements are reflected in her 21 citations, 2 h-index, and 1 i10-index, underscoring her growing influence in clinical hematology. She is a member of the European Hematology Association and the Romanian Society of Hematology, contributing to both national and international medical communities.

Profile: Google Scholar

Featured Publications

1. Ghiaur, A., Doran, C., Gaman, M. A., Ionescu, B., Tatic, A., Cirstea, M., … Stancioaica, M. C. (2024). Acute promyelocytic leukemia: Review of complications related to all-trans retinoic acid and arsenic trioxide therapy. Cancers, 16(6), 1160.

2. Mohorea‐Neata, A. L., Ghita, M. C., Moroti, R., Ghiaur, A., Ionescu, B., Tatic, A., … Stancioaica, M. C. (2023). Invasive fusariosis in acute leukaemia patients—An outbreak in the haematology ward. Mycoses, 66(8), 705–710.

3. Droc, G., Stancioaica, M. C., Soare, C. G., Stefan, M. G., Ingustu, D., Martac, C., … Ghiaur, A. (2023). Acute promyelocytic leukemia and severe differentiation syndrome in pregnancy—A management challenge. Life, 13(5), 1141.

4. Coriu, D., & Stancioaica, M. C. (2023). Moving low-risk myelodysplastic syndromes from humans to mice: Is it truly that simple? Haematologica, 109(1), 8.

5. Stancioaica, M. C., Coriu, D., & Ghiaur, G. (2025). FLT3: A 35-year voyage from discovery to the next generation of targeted therapy in AML. Cancers.